New Roaccutane formulation

Roche has launched a new 10mg strength of Roaccutane (isotretinoin) and discontinued the 5mg capsule.

Roaccutane is indicated for treatment of severe acne resistant to antibiotic and topical therapy.

Both the 10mg and existing 20mg Roaccutane capsules are now arachis oil free, however, they remain contra-indicated in patients with soya allergy.

View Roaccutane drug record

Further information: Roche

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more